GREENLANE HOLDINGS INC - A (GNLN)

US3953303019 - Common Stock

1.67  -0.09 (-5.11%)

After market: 1.6245 -0.05 (-2.72%)

Fundamental Rating

2

Taking everything into account, GNLN scores 2 out of 10 in our fundamental rating. GNLN was compared to 15 industry peers in the Distributors industry. The financial health of GNLN is average, but there are quite some concerns on its profitability. GNLN does not seem to be growing, but still is valued expensively.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

GNLN had negative earnings in the past year.
GNLN had a negative operating cash flow in the past year.
In the past 5 years GNLN always reported negative net income.
GNLN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

GNLN's Return On Assets of -39.02% is on the low side compared to the rest of the industry. GNLN is outperformed by 85.71% of its industry peers.
GNLN has a Return On Equity of -139.36%. This is amonst the worse of the industry: GNLN underperforms 92.86% of its industry peers.
Industry RankSector Rank
ROA -39.02%
ROE -139.36%
ROIC N/A
ROA(3y)-58.48%
ROA(5y)-41.21%
ROE(3y)-143.88%
ROE(5y)-131.25%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

GNLN has a Gross Margin of 47.00%. This is amongst the best in the industry. GNLN outperforms 92.86% of its industry peers.
In the last couple of years the Gross Margin of GNLN has grown nicely.
The Profit Margin and Operating Margin are not available for GNLN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.26%
GM growth 5Y6.44%

More info and screens

5

2. Health

2.1 Basic Checks

GNLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
GNLN has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, GNLN has less shares outstanding
The debt/assets ratio for GNLN is higher compared to a year ago.

2.2 Solvency

GNLN has an Altman-Z score of -11.28. This is a bad value and indicates that GNLN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -11.28, GNLN is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
There is no outstanding debt for GNLN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -11.28
ROIC/WACCN/A
WACC26.81%

2.3 Liquidity

GNLN has a Current Ratio of 1.10. This is a normal value and indicates that GNLN is financially healthy and should not expect problems in meeting its short term obligations.
GNLN has a worse Current ratio (1.10) than 85.71% of its industry peers.
A Quick Ratio of 0.44 indicates that GNLN may have some problems paying its short term obligations.
The Quick ratio of GNLN (0.44) is worse than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.44

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.53% over the past year.
Looking at the last year, GNLN shows a very negative growth in Revenue. The Revenue has decreased by -72.07% in the last year.
Measured over the past years, GNLN shows a very negative growth in Revenue. The Revenue has been decreasing by -18.24% on average per year.
EPS 1Y (TTM)55.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.12%
Revenue 1Y (TTM)-72.07%
Revenue growth 3Y-22.1%
Revenue growth 5Y-18.24%
Sales Q2Q%-65.78%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to grow by 51.19% on average over the next years. This is a very strong growth
EPS Next Y62.77%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.16%
Revenue Next 2Y51.19%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GNLN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GNLN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GNLN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREENLANE HOLDINGS INC - A

NASDAQ:GNLN (1/6/2025, 5:27:56 PM)

After market: 1.6245 -0.05 (-2.72%)

1.67

-0.09 (-5.11%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)08-12 2024-08-12
Earnings (Next)01-07 2025-01-07
Inst Owners0.79%
Inst Owner Change0%
Ins Owners0.43%
Ins Owner Change0.15%
Market Cap3.54M
Analysts43.33
Price TargetN/A
Short Float %4.63%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.16
P/FCF N/A
P/OCF N/A
P/B 0.37
P/tB 0.37
EV/EBITDA N/A
EPS(TTM)-19.6
EYN/A
EPS(NY)-5.62
Fwd EYN/A
FCF(TTM)-4.13
FCFYN/A
OCF(TTM)-3.88
OCFYN/A
SpS10.19
BVpS4.47
TBVpS4.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.02%
ROE -139.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47%
FCFM N/A
ROA(3y)-58.48%
ROA(5y)-41.21%
ROE(3y)-143.88%
ROE(5y)-131.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.26%
GM growth 5Y6.44%
F-Score4
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 39.47%
Cap/Sales 2.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 0.44
Altman-Z -11.28
F-Score4
WACC26.81%
ROIC/WACCN/A
Cap/Depr(3y)56.45%
Cap/Depr(5y)62.99%
Cap/Sales(3y)2.07%
Cap/Sales(5y)1.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.12%
EPS Next Y62.77%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-72.07%
Revenue growth 3Y-22.1%
Revenue growth 5Y-18.24%
Sales Q2Q%-65.78%
Revenue Next Year18.16%
Revenue Next 2Y51.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y73.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year115.68%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y72.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.43%
OCF growth 3YN/A
OCF growth 5YN/A